The latest news, trends, analysis, interviews and podcasts from the global food and beverage industry

Om Mushrooms, a US-based functional mushroom company, has secured a $6.5 million line of credit from JPalmer Collective (JPC), an asset-based lender specialising in high-growth, women-led and natural products businesses.

The funding is intended to support Om Mushrooms’ next stage of growth, enabling the company to meet rising consumer demand for functional mushroom products across supplements, beverages and plant-based nutrition categories.

“This funding will help us navigate growth opportunities as consumers increasingly seek out the benefits of mushrooms,” said Sandra Carter, co-founder of Om Mushrooms and M2 Ingredients. “JPC understands our business and channels in detail, serving not just as a lender but as a strategic advisor.”

Founded by Dr Carter, a health and wellness expert, and veteran mycologist Steve Farrar, Om Mushrooms has built a reputation in the functional wellness sector over more than a decade.

Its portfolio includes organic, non-GMO mushroom powders, capsules, gummies and functional beverages aimed at supporting focus, immunity, stress relief and gut health.

JPalmer Collective’s founder and CEO, Jennifer Palmer, said: “Functional mushrooms have become one of the most exciting growth areas in natural wellness, and Om has been ahead of that curve for more than a decade”.

The flexible credit line is designed to support Om Mushrooms’ scaling needs and ensure the company can respond to surging demand.

The move comes amid a broader surge in consumer interest in functional wellness and plant-based natural products, with mushrooms increasingly positioned as versatile ingredients in both supplements and functional foods and beverages.

JPalmer Collective, established in 2023, focuses on providing consultative lending solutions for women-led and high-growth consumer brands, particularly those serving sustainability-conscious markets.

Om Mushrooms products are grown in the US under certified organic conditions and undergo rigorous testing for purity and potency.

The company’s emphasis on science-backed wellness solutions positions it to capitalise on the growing functional mushroom trend, which is expected to remain a high-growth segment within the broader natural products market.